DENVER--(BUSINESS WIRE)--July 25, 2006--Myogen, Inc. (Nasdaq:MYOG - News), a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of cardiovascular disorders, today announced that it will report 2006 second quarter results the afternoon of Monday, August 7, 2006.
